| Literature DB >> 32767782 |
Georgia Papapostolou1, Hampus Kiotseridis1, Kerstin Romberg1,2, Åslög Dahl3, Leif Bjermer1, Magnus Lindgren4, David Aronsson1, Alf Tunsäter1, Ellen Tufvesson1.
Abstract
BACKGROUND: Allergic rhinitis often gives rise to impaired quality of life and is believed to also affect cognitive function. We aimed to examine whether cognitive functions were impaired during grass pollen season in symptomatic allergic children and to relate the degree of impairment to quality of life and biomarkers related to stress and inflammation.Entities:
Keywords: Cognitive function; allergic rhinitis; biomarker; pollen season; quality of life
Mesh:
Year: 2020 PMID: 32767782 PMCID: PMC7818136 DOI: 10.1111/pai.13328
Source DB: PubMed Journal: Pediatr Allergy Immunol ISSN: 0905-6157 Impact factor: 5.464
Subject characteristics
| Controls (n = 26) | Allergics (n = 43) |
| |
|---|---|---|---|
| Male/female, n (%) | 14/12 (54%/46%) | 28/15 (65%/35%) | .35 |
| Age, years | 12 (10‐15) | 12 (11‐15) | .98 |
| Number of IgE sensitizations, n | 0 (0‐1) | 4 (2‐6) | <.001 |
| House dust mite sensitized, n | 4 | 13 | .20 |
| Off‐season visit first, n (%) | 12 (46%) | 17 (39%) | .59 |
| Reporting any of the VAS symptoms | |||
| Nose, n (%) | 7 (27%) | 43 (100%) | |
| Eyes, n (%) | 4 (15%) | 43 (100%) | |
| Lungs, n (%) | 5 (19%) | 31 (72%) | |
| Overall, n (%) | 1 (4%) | 43 (100%) | |
| Cross‐reactivity, n (%) | 0 (0%) | 26 (60%) | |
p = p‐values denote comparison of controls versus allergics.
Data is presented as median (IQR).
Four of the controls and 13 of the allergics had house dust mite sensitization but no allergic symptoms related to house dust mite.
Number of participants that reported any symptoms in the different categories of VAS (visual analogue scales): Nose = secretion, congestion, itching and sneezing; Eyes = redness, itching, watery; Lungs = cough, breathlessness, wheezing and asthmatics symptoms during exercise; Overall = general condition, fatigue and impact in everyday life; Cross‐reactivity = itching and irritation in the mouth and throat, stomach pain.
FIGURE 1Grass pollen levels in Malmö, Sweden, measured daily during the study season period (May 19, 2015 to August 31, 2015)
FIGURE 2Spatial Working memory test results showing total errors (A) and total number of restarts (B) in allergic subjects and controls during off‐season and season. *p < .05 comparing allergic group and controls during pollen season
Cognitive test results from the CANTAB test in controls and allergic children off‐season and during season
| Off‐season | Season |
|
| |||||
|---|---|---|---|---|---|---|---|---|
| Controls | Allergics |
| Controls | Allergics |
| |||
| Paired associated learning (PAL)= Visual memory: episodic memory and learning | ||||||||
| Total errors | 3 (1‐6) | 3 (1‐6) | .93 | 3.5 (2‐6) | 4 (2‐8) | .61 | .60 | .37 |
| Total errors 6 shapes | 0 (0‐2) | 0 (0‐2) | .51 | 2 (0‐2) | 0 (0‐2) |
| .076 | .82 |
| Spatial Working Memory (SWM): working memory and strategy use | ||||||||
| Between errors | 17 (7‐33) | 22 (13‐31) | .53 | 13 (3‐25) | 25 (9‐37) |
|
| .13 |
| Strategy | 29 (25‐33) | 32 (29‐35) | .060 | 29 (23‐34) | 32 (28‐35) | .090 | 0.73 | 1.00 |
| Reaction time (RTI) = Attention test: speed of response and movement | ||||||||
| Simple reaction time | 276 (258‐321) | 305 (288‐343) |
| 290 (270‐330) | 312 (287‐363) | .069 | .22 | .13 |
| Simple movement time | 284 (249‐338) | 302 (247‐392) | .48 | 326 (286‐416) | 331 (275‐437) | .65 |
|
|
| Five‐choice reaction time | 317 (278‐341) | 328 (306‐376) | .10 | 324 (303‐367) | 341 (319‐396) | .16 |
|
|
| Five‐choice movement time | 309 (271‐364) | 321 (277‐417) | .63 | 340 (288‐388) | 343 (293‐440) | .58 | .43 | .32 |
| Rapid Visual Information Processing (RVIP) = Attention test: visual sustained attention | ||||||||
| A' | 0.86 (0.81‐0.90) | 0.86 (0.83‐0.89) | .59 | 0.86 (0.83‐0.88) | 0.85 (0.82‐0.89) | .77 | .43 | .17 |
| Probability of hit | 0.44 (0.32‐0.60) | 0.48 (0.37‐0.59) | .61 | 0.44 (0.33‐0.56) | 0.41 (0.33‐0.59) | .90 | .45 | .25 |
| Total false alarms | 1.0 (0.8‐4.0) | 2 (1‐3) | .73 | 2 (1‐4) | 2 (1‐4) | .43 | .39 | .14 |
| Latency | 384 (322‐464) | 364 (329‐457) | .82 | 384 (344‐477) | 382 (318‐476) | .50 | .40 | .21 |
Data are presented as median (IQR). p‐values for comparison of:
controls versus allergics during off‐season,
controls versus allergics during season
off‐season versus season in controls
off‐season versus season in allergics.
Bold values are significant values p < .05.
Health‐related quality of life Questionnaire scores in controls and allergic children off‐season and during season
| Off‐season | Season |
|
| |||||
|---|---|---|---|---|---|---|---|---|
| Controls | Allergics |
| Controls | Allergics |
| |||
| DISABKIDS | ||||||||
| Mental | 20 (20‐20) | 19 (17‐20) |
| 20 (20‐20) | 18 (17‐19) |
| .18 | .35 |
| Social | 20 (20‐20) | 19 (18‐20) |
| 20 (20‐20) | 19 (18‐20) |
| .34 | .39 |
| Physical | 10 (10‐10) | 8 (7‐9) |
| 10 (10‐10) | 8 (6‐9) |
| .14 |
|
| Total | 50 (50‐50) | 46 (43‐49) |
| 50 (50‐50) | 45 (40‐47) |
| .18 | .12 |
| VAS | ||||||||
| Nose | 0 (0‐1) | 7 (5‐8) |
| |||||
| Eyes | 0 (0‐0) | 6 (5‐8) |
| |||||
| Lungs | 0 (0‐0) | 2 (0‐7) |
| |||||
| Overall | 0 (0‐0) | 5 (4‐8) |
| |||||
| Cross‐reactivity | 0 (0‐0) | 1 (0‐3) |
| |||||
| Total | 0 (0‐2) | 22 (18‐30) |
| |||||
| LILA | ||||||||
| Practical | 0 (0‐1) | 14 (9‐23) |
| |||||
| Physical | 1 (0‐4) | 36 (25‐51) |
| |||||
| Emotional | 0 (0‐0) | 2 (0‐5) |
| |||||
| Total | 1 (0‐6) | 59 (41‐74) |
| |||||
LILA: the Swedish version of Paediatric Allergic Disease Quality of Life. Data is presented as median (IQR). p‐values for comparison of:
controls versus allergics during off‐season,
controls versus allergics during season,
off‐season versus season in controls,
off‐season versus season in allergics. VAS definitions: Nose = secretion, congestion, itching and sneezing; Eyes = redness, itching, watery; Lungs = cough, breathlessness, wheezing, and asthmatics symptoms during exercise; Overall = general condition, fatigue, and impact in everyday life; Cross‐reactivity = itching and irritation in the mouth and throat, stomach pain.
Bold values are significant values p < .05.
Biomarker concentration in controls and allergic children off‐season and during season
| Off‐season | Season |
|
| |||||
|---|---|---|---|---|---|---|---|---|
| Controls | Allergics |
| Controls | Allergics |
| |||
| Stress biomarkers | ||||||||
| Cortisol, nmol/L | 161 (122‐216) | 180 (122‐302) | .26 | 334 (192‐456) | 299 (180‐419) | .73 |
|
|
| Adrenalin, nmol/L | 0.26 (0.15‐0.39) | 0.18 (0.13‐0.27) | .061 | 0.21 (0.13‐0.29) | 0.20 (0.14‐0.28) | 8 | .27 | .82 |
| Noradrenalin, nmol/L | 2.9 (2.2‐3.5) | 2.5 (1.9‐3.1) | .15 | 2.5 (2.1‐3.5) | 2.5 (2.0‐3.5) | .57 | .88 | .53 |
| Inflammatory biomarkers | ||||||||
| IL‐13, pg/mL | 1326 (410‐5606) | 955 (125‐4458) | .45 | 1488 (281‐4919) | 809 (225‐3717) | .48 | .35 | .36 |
| TNF‐α, pg/mL | 7.1 (1.2‐47.4) | 9.7 (0.0‐66.7) | .99 | 7.3 (2.2‐66.4) | 7.5 (0.0‐60.8) | .63 | .82 | .35 |
| TGF‐β, ng/mL | 41 (30‐44) | 40 (31‐46) | .99 | 46 (30‐56) | 38 (32‐47) | .26 | .14 | .92 |
Data is presented as median (IQR). Results below detection limit were set as 0. IL‐13 = interleukin‐13, TNF‐α = tumor necrosis factor alpha, TGF‐β = transforming growth factor‐beta.
p‐values for comparison of:
controls versus allergics during off‐season,
controls versus allergics during season,
off‐season versus season in controls,
off‐season versus season in allergics.
Bold values are significant values p < .05.